Hertab 250 mg Tablet Hertab 250 mg Tablet contains lapatinib, a targeted anticancer medicine used in the treatment of HER2-positive breast cancer. It works by blocking HER2 and related growth signals in cancer cells, helping to slow or stop their growth. It may be used alone or in combination with other anticancer medicines as prescribed by an oncologist.

Effects & Benefits Helps slow the growth of HER2-positive breast cancer cells. Blocks HER2-related signaling pathways involved in cancer-cell growth. Used in eligible patients with advanced or metastatic breast cancer. May be used in combination with other anticancer medicines. Supports targeted treatment of HER2-positive breast cancer.